News

Forget the flat iron: Head Kandy debuts straightening brush

BY Gina Acosta

PONCHA SPRINGS, Colo. — There's a new tool available for women looking to keep their hair stylish, healthy and straight.

A company called Head Kandy is debuting what it calls a Straightening Brush. Sold exclusively online, the brush comes in Signature Teal, Limited Edition Apple Green, and Stole My Heart Pink. The company says it offers a tool that not only provides more effective straightening, but proves to keep hair stronger and less susceptible to the damage that often comes with traditional flat irons.

"The Head Kandy Straightening Brush is the highest quality tool in this price range on the market," said professional Hair Stylist and founder Kayla McNeill. "My passion for new and state-of-the-art products keeps me constantly on the lookout for exciting ways to improve upon traditional hair styling methods. I strive to provide effective and affordable products to allow anyone to achieve their most beautiful look without risking the health of their hair."

Head Kandy's ceramic brush is part of a new generation of hair straightening brushes. The signature brush ensures less heat damage will occur due to the fact that, unlike a flat iron, it isn't pressing hair between two plates. The brush also makes styling much more flexible and keeps the hair shinier and more manageable. It is widely recognized as a healthier option for straight hair as opposed to standard flat irons.

"I wanted to create something that would allow women to get the straight hair that they've always wanted without worrying about the damage that using a hot tool will cause," added McNeill. "Our signature Straightening Brush not only provides perfectly straight hair, but allows for the maintenance of healthy tresses as well. This is a win-win."

Head Kandy also offers a uniquely formulated Fiber Lash mascara for $25. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Perrigo completes generic Retin-A portfolio acquisition

BY David Salazar

DUBLIN — Perrigo announced Monday that it had completed its acquisition of  the Retin-A portfolio of generic products from Matawan Pharmaceuticals. From 2005 to 2013, Perrigo had been the distributor of all Retin-A generic products, which treat acne. 
 
“We are excited to complete this transaction; bringing a high barrier-to-entry, margin-enhancing product and greater reach to the extended topicals portfolio,” Perrio CEO Joseph Papa said. “This acquisition further strengthens Perrigo's strategic position as we continue our mission of providing Quality Affordable Healthcare Products to consumers around the world.”
 
Retin-A had generic and brand sales of $290 million in the 12 months ended November 2015. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

FDA approves new indication for Botox

BY DSN STAFF

SILVER SPRING, Md. — The Food and Drug Administration has approved a new indication for Allergan’s Botox (onabotulinumtoxinA). The drug can now be used to treat lower limb spasticity in adult patients as a way of decreasing the severity of muscles stiffness in ankle or toe muscles. 
 
The new indication comes just a few months after the FDA approved Botox to treat upper limb spasticity in two thumb muscles and six years after it was approved to treat upper limb spasticity in the elbow, wrist and fingers. 
 
“Spasticity is a debilitating condition that can have a significant impact on patients' lives, compromising their ability to perform a range of daily activities,” Botox SVP global development and scientific officer Dr. Mitchell Brin said. “This FDA approval marks our continued commitment to partnering with scientists and researchers around the world to explore the potential benefits of Botox in treating specific medical conditions. We are pleased that through this research, we are now able to offer this treatment option for patients with lower limb spasticity.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES